A CLASS ACTION HAS BEEN AUTHORIZED ON BEHALF OF ALL PERSONS IN CANADA WHO WERE PRESCRIBED AND USED REXULTI® FROM FEBRUARY 2017
The Plaintiffs alleged that REXULTI® causes Compulsive Behaviours and Impulse Control Disorders, including compulsive gambling, hypersexuality, compulsive shopping, and binge eating, and that the Defendants, Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc., failed to warn the Class Members and their physicians of this risk.
- The Plaintiffs alleged that REXULTI® causes Compulsive Behaviours and Impulse Control Disorders, including compulsive gambling, hypersexuality, compulsive shopping, and binge eating, and that the Defendants, Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc., failed to warn the Class Members and their physicians of this risk.
- The Defendants deny these allegations, and the Superior Court has not yet ruled on the merits of the class action.
- If you wish to remain in the action, you do not need to take any further action.
- To learn more about your rights, contact Class Counsel or visit their website at: https://www.rochongenova.com/current-class-action-cases/rexulti/